PARIS, France—Older patients with non-ST-elevation acute coronary syndrome treated with ticagrelor (Brilinta; AstraZeneca) are at a significantly increased risk ...
POPULAR AGE Supports Clopidogrel Over Ticagrelor in Elderly ACS Patients - TCTMD
Read More
Bagikan Berita Ini
0 Response to "POPULAR AGE Supports Clopidogrel Over Ticagrelor in Elderly ACS Patients - TCTMD"
Posting Komentar